A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects.
Saved in:
| Title: | A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects. |
|---|---|
| Authors: | Becker NP; Berlin Cures GmbH, Dept. Regulatory Affairs, Knesebeck Str. 59-61, 10719, Berlin, Germany., Haberland A; Berlin Cures GmbH, Dept. Regulatory Affairs, Robert-Rössle-Str. 10, 13125, Berlin, Germany. haberland@berlincures.de., Wenzel K; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany., Göttel P; Berlin Cures GmbH, COO, Knesebeck Str. 59-61, 10719, Berlin, Germany., Wallukat G; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany., Davideit H; Berlin Cures GmbH, Dept. Quality Management, Robert-Rössle-Str. 10, 13125, Berlin, Germany.; Life Molecular Imaging GmbH, Berlin, Germany., Schulze-Rothe S; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany., Hönicke AS; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany., Schimke I; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany., Bartel S; Berlin Cures GmbH, Laboratory, Robert-Rössle-Str. 10, 13125, Berlin, Germany., Grossmann M; Parexel International GmbH, Berlin, Germany., Sinn A; Parexel International GmbH, Berlin, Germany., Iavarone L; Parexel International GmbH, Berlin, Germany., Boergermann JH; Parexel International GmbH, Berlin, Germany., Prilliman K; Parexel International GmbH, Berlin, Germany.; Veristat, Southborough, MA, United States., Golor G; Parexel International GmbH, Berlin, Germany.; Biokinetica GmbH, Berlin, Germany., Müller J; Berlin Cures GmbH, CEO, Knesebeck Str. 59-61, 10719, Berlin, Germany., Becker S; Berlin Cures GmbH, Clinical Operations, Knesebeck Str. 59-61, 10719, Berlin, Germany. |
| Source: | Clinical drug investigation [Clin Drug Investig] 2020 May; Vol. 40 (5), pp. 433-447. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-1918 |
|---|---|
| DOI: | 10.1007/s40261-020-00903-9 |
